Expression of Nm23 in gliomas and its effect on migration and invasion in vitro

Anticancer Research

Volumn 26, Issue 1 A, 2006, Pages 249-258

  Jung, Shin ^a,b   Paek, Yun Woong ^a   Moon, Kyung Sub ^a   Wee, Sung Chan ^a   Ryu, Hyang Hwa ^a   Jeong, Young Il ^a   Sun, Heung Suk ^a   Jin, Yong Hao ^a   Kim, Kyung Keun ^a   Ahn, Kyu Youn ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Hwasun Hospital and Medical School   (South Korea)

Author keywords

Glioma; Invasion; Migration; nm23

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A;

ARTICLE; BRAIN SLICE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MULTIGENE FAMILY; NM23 GENE; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ASTROCYTOMA; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HUMANS; NEOPLASM INVASIVENESS; NUCLEOSIDE-DIPHOSPHATE KINASE; TRANSFECTION;

EID: 32144460349     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Giese A and Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39: 235-252, 1996.
2. Liotta LA, Stetler Stevenson WG and Steeg PS: Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9: 543-551, 1991.
3. Tanaka M, Tomita A, Yoshida S, Yano M and Shimizu H: Observation of the highly organized development of granule cells in rat cerebellar organotypic cultures. Brain Res 641: 319-327, 1994.
4. Leone A, Flatow U, VanHoutte K and Steeg PS: Transfection of human nm23H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization, and enzymatic activity. Oncogene 8: 2325-2333, 1993.
5. Miyazaki H, Fukuda M, Ishijima Y, Takagi Y, Iimura T, Negishi A, Hirayama R, Ishikawa N, Amagasa T and Kimura N: Overexpression of nm23H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastsis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clin Cancer Res 5: 4301-4307, 1999.
6. Parhar RS, Shi Y, Zou M, Farid NR, Ernst P and al-Sediary ST: Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int J Cancer 60: 204-210, 1995.
7. Tagashira H, Hamazaki K, Tanaka N, Gao C and Namba M: Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23R2 rat nucleoside diphosphate kinase A isoform. Int J Mol Med 2: 65-68, 1998.
8. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190, 1989.
9. Postel EH: NM23-NDP kinase. Int J Biochem Cell Biol 30: 1291-1295, 1998.
10. Roymans D, Willems R, Vissenberg K, De Jonghe C, Grobben B, Claes P, Lascu I, Van Bockstaele D, Verbelen JP, Van Broeckhoven C and Siegers H: Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma. Exp Cell Res 261: 127-138, 2000.
11. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
12. Ayabe T, Tomita M, Matsuzaki Y, Ninomiya H, Hara M, Shimizu T, Edagawa M, Onitsuka T and Hamada M: Micrometastasis and expression of nm23 messenger RNA of lymph nodes from lung cancer and the postoperative clinical outcome. Ann Thorac Cardiovasc Surg 10: 152-159, 2004.
13. Caligo MA, Cipollini G, Berti A, Viacava P, Collecchi P and Bevilacqua G: NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression. Int J Cancer 74: 102-111, 1997.
14. Stark AM, Tongers K, Maass N, Mehdorn HM and Held-Feindt J: Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131: 191-198, 2005.
15. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
16. Mattson DL and Higgins DJ: Influence of dietary sodium intake on renal medullary nitirc oxide synthases. Hypertension 27: 688-692, 1996.
17. Abassi Z, Gurbanov K, Rubinstein I, Better OS, Hoffman A and Winaver J: Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide. Am J Physiol 274: 766-774, 1998.
18. Jung S, Ackerley C, Ivanchuk S, Mondal S, Becker LE and Rutka JT: Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organotypical brain slice model. J Neurosurg 94: 80-89, 2001.
19. Jung S, Hinek A, Tsugu A, Hubbard SL, Ackerley C, Becker LE and Rutka JT: Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential. Glia 25: 179-189, 1999.
20. Boissan M, Wendum D, Arnaud-Dabernat S, Munier A, Debray M, Lascu I, Daniel JY and Lacombe ML: Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst 97: 836-845, 2005.
21. Graham ANJ, Maxwell P, Mulholland K, Patterson AH, McManus KG, Bharucha H and McGuigan JA: Increased nm23 immunoreactivity is associated with selective inhibition of systemic tumour cell dissemination. J Clin Pathol 55: 184-190, 2002.
22. Kapitanovic S, Cacev T, Berkovic M, Popovic-Hadzija M, Radosevic S, Seiwerth S, Spaventi S, Pavelic K and Spaventi R: Nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol 57: 1312-1318, 2004.
23. Ohta S, Lai EW, Pang AL, Brouwers FM, Chan WY, Eisenhofer G, de Krijger R, Ksinantova L, Breza J, Blazicek P, Kvetnansky R, Wesley RA and Pacak K: Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer 114: 139-143, 2005.
24. Chang CL, Zhu XX, Thoraval DH, Ungar D, Rawwas J, Hora N, Strahler JR, Hanash SM and Radany E: Nm23-H1 mutation in neuroblastoma. Nature 370: 335-336, 1994.
25. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F and Starhler JR: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88: 341-345, 1991.
26. Lacombe ML, Sastre-Garau X, Lascu I, Vonica A, Wallet V, Thiery JP and Veron M: Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. Eur J Cancer 27: 1302-1307, 1991.
27. Martin KK, Pilkington GJ: Nm23: an invasion suppressor gene in CNS tumours? Anticancer Res 18: 919-926, 1998.
28. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy RLJ, Shows TB, Mathew S, Murty W and Chaganti RS: Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 8: 497-502, 1993.
29. Stahl JA, Leone A, Rosengard AM, Porter L, King CR and Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 51: 445-449, 1991.
30. Lakshmi MS, Parker C and Sherbet GV: Metastasis associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: a possible mechanism of their regulation of metastatic behaviour of tumours. Anticancer Res 13: 299-303, 1993.
31. 2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma. Melanoma Res 2: 337-343, 1992.
32. Hartsough MT, Morrison DK, Salerno M, Palmieri D, Ouatas T, Mair M, Patrick J and Steeg PS: Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 277: 32389-32399, 2002.
33. MacDonald NJ, De la Rosa A, Benedict MA, Freije JM, Krutsch H and Steeg PS: A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268: 25780-25789, 1993.
34. Caligo MA, Cipollini G, Fiore L, Calvo S, Basolo F, Collecchi P, Ciardiello F, Pepe S, Petrini M and Bevilacqua G: NM23 gene expression correlates with cell growth rate and S-phase. Int J Cancer 60: 837-842, 1995.
35. Igawa M, Rukstalis DB, Tanabe T and Chodak GW: High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res 54: 1313-1318, 1994.
36. Ma D, McCorkle JR, Kaetzel DM: The metastasis suppressor NM23-H1 possesses 3′-5′ xonuclease activity. J Biol Chem 279: 18073-18084, 2004.
37. Postel EH, Weiss VH, Beneken J and Kirtane A: Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element. Proc Natl Acad Sci USA 93: 6892-6897, 1996.
38. Hsu S, Huang F, Ossowski L and Friedman E: Colon carcinoma cells with inactive nm23 show increased motility and response to motility factors. Carcinogenesis 16: 2259-2262, 1995.
39. Kantor JD, McCormick B, Steeg PS and Zetter BR: Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 53: 1971-1973, 1993.
40. Wang SW, Yam HF, Yang L, Ng HK, Wang SL, Wu BQ, Wang ZH, Chew-Cheng B and Chew EC: Expression of nm23-H1 in human meningioma cells. Anticancer Res 17: 3569-3573, 1997.
41. Nawashiro H, Ozeki Y, Takishima K, Shima K and Chigasaki H: Immunohistochemical analysis of the nm23 gene product (NDP kinase) expression in astrocytic neoplasms. Acta Neurochir (Wien) 138: 445-450, 1996.
42. Takino H, Herman V, Weiss M and Melmed S: Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab 80: 1733-1738, 1995.
43. Pilkington GJ, Darling JL, Lantos PL and Thomas DG: Tumorigenicity of cell lines (VMDk) derived from a spontaneous murine astrocytoma: histology, fine structure and immunocytochemistry of tumours. J Neurol Sci 71: 145-164, 1985.
44. Murugesan G, Chisholm GM and Fox PL: Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol 120: 1011-1019, 1993.
45. Janiak M, Hashmi HR and Janowska-Wieczorek A: Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. Exp Hematol 22: 559-565, 1994.
46. Bjerkvig R, Toennessen A, Laerum OD and Backlund EO: Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475, 1990.
47. Pedersen PH, Rucklidge GJ, Mork SJ, Terzis AJ, Engebraaten O, Lund-Johansen M, Backlund EO, Laerum OD and Bjerkvig R: Leptomeningeal tissue: a barrier against brain tumor cell invasion. J Natl Cancer Inst 86: 1593-1599, 1994.
48. Chishima T, Miyagi Y, Wang X, Yamaoka H, Shimada H, Moossa AR and Hoffman RM: Governing step of metastasis visualized in vitro. Proc Natl Acad Sci USA 94: 11573-11576, 1997.